GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hemogenyx Pharmaceuticals HEMO.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

565.00p

-0.88%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Hemogenyx Pharmaceuticals — daily HEMO

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Hemogenyx Pharmaceuticals on TradingView ↗
Market value
£18.7m
Last close × shares
Volume
1.3k
Shares, 9 Nov 2026

About Hemogenyx Pharmaceuticals

Its shares trade on LSE under the ticker HEMO.L. It has been listed since 9 November 2015.

HemoGenyx Pharmaceuticals Plc operates as a biopharmaceutical company, which engages in the development of novel therapies to transform bone marrow and blood stem cell transplantation. The firm is focused on developing new treatments for blood diseases such as leukaemia, lymphoma and blood marrow failure. Its therapies are designed to provide new treatments in bone marrow/stem cell transplants, improving the success and safety of such treatments. Its products include Conditioning and Cell therapy product. Conditioning product is for CDX bi-specific antibodies, redirects a patient’s own immune cells to eliminate unwanted blood stem cells preparing a patient for bone marrow (also known as haematopoietic stem cell) transplantation. Cell therapy product uses human postnatal hemogenic endothelial cells (HuPHECs) to generate cancer-free, patient-matched blood stem cells after transplant into the patient.

Figures and description from our data supplier, not checked against the company's own report.

More about Hemogenyx Pharmaceuticals →

Latest on Hemogenyx Pharmaceuticals

Our reporting

We have not reported on Hemogenyx Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Hemogenyx Pharmaceuticals's ticker?

Hemogenyx Pharmaceuticals trades as HEMO.L on LSE, under ISIN GB00BQVXM815.

What was Hemogenyx Pharmaceuticals's last closing price?

565.00p on 9 Nov 2026. The figure is in GBp and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.